Holds one active US DMF and 2 valid CEPs for pyrazinamide, filing since 2016. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.
Holds one valid CEP for pyrazinamide, filing since 2026. Its 2026 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for pyrazinamide, filing since 2001. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for pyrazinamide, filing since 2019. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for pyrazinamide, filing since 2001. Its 2024 FDA inspection closed as OAI, and its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystContract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for pyrazinamide and what filings they hold.
Chat with Fred, your AI analyst| Year | Median | Exporters |
|---|---|---|
| 2025 | $22.92 | 9 |
| 2024 | $23.00 | 5 |
| 2023 | $22.85 | 5 |
| 2022 | $22.25 | 6 |
US dollars per kilogram, customs export unit values.